BioMarin Pharmaceutical
BMRN
#1907
Rank
C$14.17 B
Marketcap
C$73.77
Share price
-0.78%
Change (1 day)
-20.48%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): C$0.95 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$3.09 Billion. In 2024 the company made an earning of C$0.74 Billion, an increase over its 2023 earnings that were of C$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.95 B27.55%
2024 C$0.74 B187.31%
2023 C$0.26 B26.07%
2022 C$0.20 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$58.47 Million-55.36%
2019 -C$0.14 Billion-33.56%
2018 -C$0.2 Billion297.78%
2017 -C$49.57 Million-95.68%
2016 -C$1.15 Billion437.12%
2015 -C$0.22 Billion23.91%
2014 -C$0.18 Billion-29.25%
2013 -C$0.25 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$60.28 Million103.01%
2010 -C$29.69 Million-3903.54%
2009 C$0.78 M-98.31%
2008 C$46.17 M-189.7%
2007 -C$51.48 Million51.02%
2006 -C$34.09 Million-61.58%
2005 -C$88.72 Million-56.59%
2004 -C$0.21 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$93.43 Million73.19%
2001 -C$53.95 Million18.32%
2000 -C$45.6 Million19.65%
1999 -C$38.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$37.91 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.57 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
C$6.88 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$0.39 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA